- Home
- NPWR vs BDTX Comparison
NPWR vs BDTX Comparison
Compare NPWR & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPWR
- BDTX
- Stock Information
- Founded
- NPWR 2010
- BDTX 2014
- Country
- NPWR United States
- BDTX United States
- Employees
- NPWR N/A
- BDTX N/A
- Industry
- NPWR Industrial Machinery/Components
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NPWR Energy
- BDTX Health Care
- Exchange
- NPWR Nasdaq
- BDTX Nasdaq
- Market Cap
- NPWR 171.3M
- BDTX 181.4M
- IPO Year
- NPWR N/A
- BDTX 2020
- Fundamental
- Price
- NPWR $3.56
- BDTX $3.90
- Analyst Decision
- NPWR Buy
- BDTX Strong Buy
- Analyst Count
- NPWR 2
- BDTX 5
- Target Price
- NPWR $4.00
- BDTX $12.00
- AVG Volume (30 Days)
- NPWR 1.3M
- BDTX 1.0M
- Earning Date
- NPWR 11-10-2025
- BDTX 11-04-2025
- Dividend Yield
- NPWR N/A
- BDTX N/A
- EPS Growth
- NPWR N/A
- BDTX N/A
- EPS
- NPWR N/A
- BDTX 0.25
- Revenue
- NPWR $12,000.00
- BDTX $70,000,000.00
- Revenue This Year
- NPWR N/A
- BDTX N/A
- Revenue Next Year
- NPWR N/A
- BDTX N/A
- P/E Ratio
- NPWR N/A
- BDTX $15.62
- Revenue Growth
- NPWR N/A
- BDTX N/A
- 52 Week Low
- NPWR $1.48
- BDTX $1.20
- 52 Week High
- NPWR $14.28
- BDTX $4.03
- Technical
- Relative Strength Index (RSI)
- NPWR 68.86
- BDTX 68.52
- Support Level
- NPWR $2.94
- BDTX $3.62
- Resistance Level
- NPWR $3.87
- BDTX $4.03
- Average True Range (ATR)
- NPWR 0.32
- BDTX 0.21
- MACD
- NPWR 0.10
- BDTX 0.05
- Stochastic Oscillator
- NPWR 81.25
- BDTX 86.63
About NPWR NET Power Inc.
NET Power Inc is a clean energy technology company that has developed a novel power generation system, which it refers to as the NET Power Cycle, designed to produce clean, reliable, and low-cost electricity from natural gas while capturing virtually all atmospheric emissions. The company's business model is to license its technology to customers and enable them to build, own, and operate facilities that utilize the Net Power Cycle. It has conducted a successful demonstration of its technology at the La Porte Demonstration Facility and is developing a utility-scale power plant in Texas named Project Permian.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.